Drug Profile
Research programme: autoimmune disorders - Celltech
Alternative Names: Autoimmune disorders research programme - Celltech; Research programme: scurfy gene - Celltech; Scurfy gene research programme - CelltechLatest Information Update: 20 Sep 2007
Price :
$50
*
At a glance
- Originator Celltech R&D
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Autoimmune disorders
Most Recent Events
- 02 May 2001 Celltech Chiroscience Discovery is now called Celltech R&D
- 02 Feb 2000 Medeva has been merged into Celltech Chiroscience, which is now called Celltech Group
- 21 Oct 1999 Chiroscience has merged with Celltech to form Celltech Chiroscience